The development of sarcoidosis with the use of alemtuzumab - Clues to T-cell immune reconstitution [4]

British Journal of Haematology

Volumn 138, Issue 4, 2007, Pages 559-560

  Thachil, Jecko ^a   Jadhav, Vittal ^a   Gautam, Manish ^a   Mckew, Steve ^a   Arumainathan, Arvind ^a   Collins, Daniel ^a   Smyth, Colin ^a   Harper, Janice ^a   Pettitt, Andrew ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Alemtuzumab; Immune reconstitution; Sarcoidosis; T cells

Indexed keywords

ALEMTUZUMAB; EMOLLIENT AGENT; ISOTRETINOIN; PREDNISOLONE;

ADULT; BONE MARROW EXAMINATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; FOLLICULITIS; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LETTER; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SARCOIDOSIS; SEZARY SYNDROME; SKIN BIOPSY; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; CD4-CD8 RATIO; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; SARCOIDOSIS; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 34447319089     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06687.x     Document Type: Letter

References (10)

1. Baughman, R.P., Lower, E.E. du Bois, R.M. (2003) Sarcoidosis. Lancet, 361, 1111 1118.
2. Hoffmann, R.M., Jung, M.C., Motz, R., Gossl, C., Emslander, H.P., Zachoval, R. Pape, G.R. (1998) Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. Journal of Hepatology, 28, 1058 1063.
3. Katchar, K., Eklund, A. Grunewald, J. (2003) Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. Journal of Internal Medicine, 254, 564 571.
4. Lundin, J., Hagberg, H., Repp, R., Cavallin-Stahl, E., Freden, S., Juliusson, G., Rosenblad, E., Tjonnfjord, G., Wiklund, T. Osterborg, A. (2003) Phase 2 study of alemtuzumab (anti- CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome. Blood, 101, 4267 4272.
5. Moller, D.R., Forman, J.D., Liu, M.C., Noble, P.W., Greenlee, B.M., Vyas, P., Holden, D.A., Forrester, J.M., Lazarus, A., Wysocka, M., Trinchieri, G. Karp, C. (1996) Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. Journal of Immunology, 156, 4952 4960.
6. Pietropaoli, A., Modrak, J. Utell, M. (1999) Interferon- therapy associated with the development of sarcoidosis. Chest, 116, 569 572.
7. Rezvany, M.R., Tehrani, M.J., Karlsson, C., Lundin, J., Rabbani, H., Osterborg, A. Mellstedt, H. (2006) Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 135, 475 485.
8. Rogge, L., D'Ambrosio, D., Biffi, M., Penna, G., Minetti, L.J., Presky, D.H., Adorini, L. Sinigaglia, F. (1998) The role of Stat4 in species-specific regulation of Th cell development by type I interferons. Journal of Immunology, 161, 6567 6574.
9. Teragawa, H., Hondo, T., Takahashi, K., Watanabe, H., Ohe, H., Hattori, N., Watanabe, Y., Amano, H., Hino, F., Ohbayashi, M., Urushihara, T. Yonehara, S. (1996) Sarcoidosis after interferon therapy for chronic active hepatitis C. Internal Medicine, 35, 19 23.
10. Vander Els, N.J. Gerdes, H. (2000) Sarcoidosis and Interferon-alpha treatment. Chest, 117, 294.